Surgical treatment of melanoma patients with early sentinel node involvement

Current Treatment Options in Oncology

Volumn 13, Issue 3, 2012, Pages 318-326

  Hardin, Rosemarie E ^a   Lange, Julie R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

lymph node dissection; melanoma; sentinel node

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; LYMPHEDEMA; MELANOMA; MORBIDITY; OVERALL SURVIVAL; PATIENT SELECTION; POST TREATMENT SURVIVAL; POSTOPERATIVE INFECTION; RISK BENEFIT ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE DISSECTION; SENTINEL LYMPH NODE METASTASIS; TREATMENT OUTCOME; TUMOR VOLUME; WOUND COMPLICATION;

CLINICAL TRIALS AS TOPIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; SENTINEL LYMPH NODE BIOPSY; TUMOR BURDEN;

EID: 84865680879     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-012-0202-8     Document Type: Article

References (27)

1. R Siegel D Naishadham A Jemal 2012 Cancer statistics, 2012. CA A Cancer J Clin 62 10 29 10.3322/caac.20138
2. CM Balch SJ Soong JE Gershenwald, et al. 2001 Prognostic factors analysis of 1600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622 34 11504744 1:STN:280: DC%2BD3MvlvV2ktA%3D%3D
3. RR White WE Stanley JJ Johnson, et al. 2002 Long-term survival in 2505 patients with melanoma with regional lymph node metastasis Ann Surg 235 879 87 12035046 10.1097/00000658-200206000-00017
4. H Snow 1892 Melanotic cancerous disease Lancet 2 872 4
5. DL Morton DR Wen JH Wong, et al. 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392 9 1558490 10.1001/archsurg.1992.01420040034005 1:STN:280:DyaK383hsFWjsw%3D%3D
6. D Reintgen CW Cruse K Wells, et al. 1994 The orderly progression of melanoma nodal metastases Arch Surg 220 759 67 1:STN:280:DyaK2M%2FnslCktQ%3D%3D
7. JF Thompson WH McCarthy CM Bosch, et al. 1995 Sentinel lymph node status as an indicator of metastatic melanoma in regional lymph nodes Melanoma Res 4 255 60 10.1097/00008390-199508000-00008
8. A Van Akkooi CA Voit C Verhoef, et al. 2012 New developments in sentinel node staging in melanoma: controversies and alternatives Curr Opin Oncol 22 169 77 10.1097/CCO.0b013e328337aa78
9. DL Morton JF Thompson AJ Cochran, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 17 17005948 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D
10. DG Coit R Andtbacka CJ Anker, et al. 2012 Melanoma J Natl Compr Cancer Netw 10 366 400 1:CAS:528:DC%2BC38XlsVSrurc%3D This is an excellent reference that provides the 2011 NCCN guidelines for management of patients with melanoma, including the current indications for sentinel lymph node biopsy. The NCCN guidelines support completion lymph node dissection as the current standard of care for patients with a positive sentinel lymph node.
11. A Van der Ploeg A van Akkooi P Rutkowski, et al. 2011 Prognosis in patients with sentinel-node positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria J Clin Oncol 29 2206 14 21519012 10.1200/JCO.2010.31.6760 This study reports that the burden of disease in the positive sentinel node is associated with prognosis of melanoma patients.
12. KM McMasters RD Noyes DS Reintgen, et al. 2004 Lessons learned from the Sunbelt Melanoma Trial J Clin Oncol 86 212 23
13. DL Morton AJ Cochran JF Thompson, et al. 2005 Sentinel node biopsy for early stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial Ann Surg 242 202 313
14. MB Faries JF Thompson A Cochran, et al. 2010 The impact on morbidity and length of stay of early vs delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (1) Ann Surg Oncol 1 3324 29 10.1245/s10434-010-1203-0 Data from the MSLT 1 trial demonstrates that early completion nodal dissection in melanoma patients with a positive sentinel lymph node has less morbidity than delayed lymphadenectomy in patients who have a clinical relapse in an observed node basin.
15. KM McMasters SL Wong MJ Edwards, et al. 2002 Frequency of nonsentinel lymph node metastasis in melanoma Ann Surg Oncol 9 137 41 11888869 10.1007/BF02557364
16. JE Gershenwald R Andtbacka VG Prieto, et al. 2008 Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma J Clin Oncol 26 4296 303 18606982 10.1200/JCO.2007.15.4179
17. R Murali C Desilva JF Thompson, et al. 2010 Non-sentinel node risk score (N-SORE): a scoring system for accurately stratisfying risk of nonsentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes J Clin Oncol 28 4441 9 20823419 10.1200/JCO.2010.30.9567 This study reports on factors associated with the likelihood of finding positive nonsentinel nodes in patients with positive sentinel nodes.
18. JH Lee R Essner H Torisu-Itakura, et al. 2004 Factors predictive of tumor positive nonsentinel lymph node after tumor positive sentinel lymph node dissection for melanoma J Clin Oncol 22 3677 84 15365064 10.1200/JCO.2004.01.012
19. RA Scolyer R Murali I Satzger, et al. 2008 The detection and significance of melanoma micrometastases in sentinel nodes Surg Oncol 17 165 74 18639451 10.1016/j.suronc.2008.06.005
20. A Van Akkooi Z Nowecki C Voit, et al. 2008 Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes Ann Surg 248 949 55 19092339 10.1097/SLA.0b013e31818fefe0
21. RP Scheri R Essner R Turner, et al. 2007 Isolated tumor cells in the sentinel node affect long term prognosis of patients with melanoma Ann Surg Oncol 14 2861 66 17882497 10.1245/s10434-007-9472-y
22. R Murali C DeSilva S Mccarthy, et al. 2012 Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative Ann Surg Oncol 19 1089 99 22271204 10.1245/s10434-011-2208-z
23. RA Scolyer R Murali JE Gershenwald, et al. 2007 Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell Ann Surg Oncol 18 806 8 1:STN:280:DC%2BD2s7ovVaqtA%3D%3D
24. SL Wong DL Morton JF Thompson, et al. 2006 melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study Ann Surg Oncol 13 809 16 16604476 10.1245/ASO.2006.03. 058
25. PT Kingham KS Panageas C Ariyan, et al. 2010 Outcomes in patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy Ann Surg Oncol 17 514 20 19924486 10.1245/s10434-009-0836-3
26. KY Bilimoria CM Balch DJ Bentrem, et al. 2008 Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States Ann Surg Oncol 15 1566 76 18414952 10.1245/s10434-008-9885- 2
27. AE Giuliano KK Hunt KV Ballman, et al. 2011 Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. A randomized clinical trial JAMA 305 569 75 21304082 10.1001/jama.2011.90 1:CAS:528:DC%2BC3MXhvVymtrg%3D